RUO supplier
Regulatory record only; full company profile not yet reviewed
Linked public records
The FDA stated that products offered by Gram Peptides were unapproved new drugs and that website content evidenced intended human-drug use despite research-use-only labeling.
Compounds: Retatrutide, Tirzepatide
Read the primary-source recordThis record exists to connect a primary-source regulatory action to a company entity. It is not a current supplier assessment.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.